Literature DB >> 29149361

[Light at the end of the tunnel].

S Delorme1, C Herold2, H-P Schlemmer3.   

Abstract

Mesh：

Year:  2017        PMID： 29149361     DOI： 10.1007/s00117-017-0315-y

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


× No keyword cloud information.
  7 in total

Review 1.  [Adverse effects of immunotherapy : Clinical aspects, radiological and nuclear medicine results].

Authors:  G Widmann; V A Nguyen; J Plaickner; W Jaschke
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

Review 3.  [Immunotherapy as modern tumor treatment].

Authors:  C Grüllich
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 4.  [Malignant melanoma : Current status].

Authors:  J K Winkler; K Buder-Bakhaya; A Dimitrakopoulou-Strauss; A Enk; J C Hassel
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 5.  [Response evaluation in nuclear medicine : Criteria, results and pitfalls].

Authors:  J Hoffend; C Sachpekidis; A Dimitrakopoulou-Strauss
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 6.  [Personalized oncology].

Authors:  C Heining; P Horak; S Gröschel; H Glimm; S Fröhling
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

Review 7.  [Radiological response assessment of modern immunotherapy using iRECIST].

Authors:  T Persigehl; T D Poeppel; O Sedlaczek
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.